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A
 
BSTRACT
 
Background
 
Acute changes in cerebral function
after elective coronary bypass surgery are a difficult
clinical problem. We carried out a multicenter study
to determine the incidence and predictors of — and
the use of resources associated with — perioperative
adverse neurologic events, including cerebral injury.
 
Methods
 
In a prospective study, we evaluated 2108
patients from 24 U.S. institutions for two general cat-
egories of neurologic outcome: type I (focal injury, or
stupor or coma at discharge) and type II (deterioration
in intellectual function, memory deficit, or seizures).
 
Results
 
Adverse cerebral outcomes occurred in
129 patients (6.1 percent). A total of 3.1 percent had
type I neurologic outcomes (8 died of cerebral injury,
55 had nonfatal strokes, 2 had transient ischemic at-
tacks, and 1 had stupor), and 3.0 percent had type II
outcomes (55 had deterioration of intellectual func-
tion and 8 had seizures). Patients with adverse cere-
bral outcomes had higher in-hospital mortality (21
percent of patients with type I outcomes died, vs. 10
percent of those with type II and 2 percent of those
with no adverse cerebral outcome; P
 

 
0.001 for all
comparisons), longer hospitalization (25 days with
type I outcomes, 21 days with type II, and 10 days
with no adverse outcome; P
 

 
0.001), and a higher
rate of discharge to facilities for intermediate- or
long-term care (47 percent, 30 percent, and 8 percent;
P
 

 
0.001). Predictors of type I outcomes were proxi-
mal aortic atherosclerosis, a history of neurologic
disease, and older age; predictors of type II outcomes
were older age, systolic hypertension on admission,
pulmonary disease, and excessive consumption of
alcohol.
 
Conclusions
 
Adverse cerebral outcomes after cor-
onary bypass surgery are relatively common and se-
rious; they are associated with substantial increases
in mortality, length of hospitalization, and use of in-
termediate- or long-term care facilities. New diagnos-
tic and therapeutic strategies must be developed to
lessen such injury. (N Engl J Med 1996;335:1857-63.)
 
©1996, Massachusetts Medical Society.
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TROKE, the third leading cause of death
in the United States, will continue to be a
challenging problem as the population ages.
Patients who undergo myocardial revascular-
ization procedures, now more than 800,000 a year
throughout the world, are particularly prone to
stroke, encephalopathy, and other neurologic dys-
function, because they are relatively old and have ath-
erosclerotic disease. They are also subject to marked
hemodynamic fluctuations; cerebral embolization of
atherosclerotic plaque, air, fat, and platelet aggre-
gates; cerebral hyperthermia after the discontinua-
tion of cardiopulmonary bypass; and other inflam-
matory and neurohumoral derangements associated
with surgery.
 
1-5
 
 
Although cerebral complications are responsible
for an increasing proportion of perioperative deaths,
 
6,7
 
their incidence and effects have not been rigorously
investigated. The majority of studies have been per-
formed only at one center, have enrolled a limited
number of patients, or have been retrospective (all of
which has resulted in substantial variability among
findings). Among the studies, for example, there is a
more than 10-fold variation in the reported incidence
of perioperative stroke (from 0.4 to 5.4 percent) and
S
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a 3-fold variation (25 to 79 percent) in that of in-
hospital neuropsychological dysfunction.
 
3,4,8,9
 
 Studies
of perioperative stroke have not attempted to identify
potentially reversible risk factors, nor have they exam-
ined the long-term impact of perioperative cerebral
outcomes on the use of resources.
 
3,7,10
 
 
Our investigation was designed as a multi-institu-
tional, prospective, observational study to determine
the incidence of both stroke and encephalopathy af-
ter coronary-artery bypass graft (CABG) surgery, to
identify the independent predictors of these cerebral
outcomes, and to define their impact on the use of
resources, as measured by the lengths of hospital
stays and the need for intensive intermediate- or
long-term care. 
 
METHODS
 
The cardiac surgery study of the Multicenter Study of Perioper-
ative Ischemia was a prospective observational study that enrolled
2417 patients who underwent elective CABG surgery in 24 U.S.
medical institutions between September 1991 and September
1993. The goals of the study were to define the incidence of ad-
verse perioperative outcomes, to measure the prevalence of select-
ed characteristics of the patients, and to assess the use of resources.
At each of the centers, between 100 and 108 patients were pro-
spectively enrolled according to a systematic sampling scheme, and
perioperative demographic, clinical, and laboratory data were col-
lected on the patients from hospital entry to discharge. Data on
all patients with new perioperative neurologic findings were inde-
pendently reviewed by six investigators, who examined additional
data (computed-tomography findings, autopsy reports, and hospi-
tal-discharge summaries) if necessary. Final classification of out-
come was made by consensus of this panel in two categories: type
I was defined as death due to stroke or hypoxic encephalopathy,
nonfatal stroke, transient ischemic attack (TIA), or stupor or coma
at the time of discharge; and type II was defined as a new deteri-
oration in intellectual function, confusion, agitation, disorienta-
tion, memory deficit, or seizure without evidence of focal injury.
Because the two types of neurologic outcome were assumed to
have different causes and predictors, and because the predictors for
type I outcome could potentially mask those for type II, patients
with more than one type of neurologic outcome were classified,
for analytic purposes, hierarchically, according to the severity of
outcome. Type I outcomes were considered more severe than type
II. Within type I, the diagnoses were ranked from most to least
severe: fatal injury, stroke, stupor or coma, and TIA. The type II
diagnoses were ranked in a similar fashion. 
Patients excluded from the analysis (n
 

 
309) could not be eval-
uated for neurologic outcome (6 patients), had undergone con-
comitant intracardiac or vascular procedures (299 patients), or had
died during surgery (4 patients) (none died of cerebral causes).
Variables considered potential predictors of neurologic outcome
were categorized according to operative stage as preoperative (e.g.,
age, sex, a history of congestive heart failure or of CABG), intra-
operative (e.g., the duration of cardiopulmonary bypass and aortic
cross-clamping, surgical and anesthetic technique, hemodynamic
changes, the use of transfusions), and postoperative (e.g., myocar-
dial infarction, dysrhythmia, ventricular dysfunction). The use of
resources was assessed on the basis of (1) the length of stay in the
intensive care unit and the total postsurgical stay in the hospital,
and (2) the site to which the patient was discharged (his or her
home or an intermediate- or long-term care facility).
 
Statistical Analysis
 
The univariable associations between adverse neurologic out-
come (type I or type II) and potential predictors were assessed
with either Fisher’s exact test or the Kruskal–Wallis test, as appro-
priate. Stepwise logistic regression was then performed separately
for type I and type II outcomes, including predictors associated
with P values no greater than 0.20 in univariable analyses and
keeping predictors with P values no greater than 0.15 in the mul-
tivariable model. All models were sorted with Akaike’s informa-
tion criterion (AIC)
 
11
 
; goodness of fit for each model was deter-
mined with the Hosmer–Lemeshow test.
 
12
 
 The model with the
lowest AIC was considered to have the best fit.
The data in this study produced several models with similar low
AIC values. Our final model was chosen on the basis of clinical
relevance, and not all variables reached a P value of 0.05 or less.
Results are reported as odds ratios with associated 95 percent
confidence intervals.
 
RESULTS
 
Demographic and operative characteristics of the
2108 patients in this study are presented in Table 1.
Patients were relatively old (32 percent were 70 years
of age or more) and had a history of hypertension,
unstable angina, heart failure, or diabetes; approxi-
mately 8 percent had a history of stroke or transient
ischemic attack. A total of 6.1 percent of the patients
(129) had perioperative adverse cerebral outcomes.
Type I outcomes occurred in 3.1 percent (66), in-
cluding 8 deaths due to cerebral injury, 55 nonfatal
strokes, 2 TIAs, and 1 case of stupor at the time of
discharge. Type II outcomes occurred in 3.0 percent
(63), including 55 with deterioration in intellectual
function and 8 with seizures. The outcome rates, ac-
cording to institution, ranged from 1 percent to 13.8
percent (range for type I outcomes alone, 0 to 8.6
percent; for type II, 0 to 9.3 percent).
 
Predictors of Type I and Type II Outcomes
 
On the basis of our univariable analysis (Table 1),
logistic regression identified eight independent pre-
dictors of type I cerebral outcomes (Table 2). Proxi-
mal aortic atherosclerosis, as identified by the cardiac
surgeon, was the strongest independent predictor, as-
sociated with a more than fourfold increase in risk. It
was followed by a history of neurologic disease, an
age of 70 or more (Fig. 1), and a history of pulmo-
nary disease. Both perioperative hypotension and the
use of a ventricular venting procedure during sur-
gery, although their point estimates were not statis-
tically significant, were included in the final model
since they did not detract from the statistical fit of
the model and they have clinical relevance. Adjust-
ment for the study site did not affect the results of
the multivariable model. Ten independent predictors
of type II cerebral outcome were identified, of which
seven were statistically significant (P
 

 
0.05) (Table
2). Predictors unique to type II were a history of ex-
cessive alcohol consumption, prior CABG surgery,
dysrhythmia, a history of peripheral vascular disease,
and congestive heart failure on the day of surgery (al-
though the last two were not statistically significant).
Predictors common to both type I and type II out-
comes were older age, a history of pulmonary dis-
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ease, a history of hypertension or existing hyperten-
sion, and perioperative hypotension.
 
Postoperative Course
 
Type I outcomes were associated with an approx-
imately 10-fold increase in in-hospital mortality, and
type II with an approximately 5-fold increase (Table
3). Similarly, the average length of the postsurgical
hospital stay and the amount of time spent in inten-
sive care were at least doubled in the patients with
adverse cerebral outcomes. Of the patients with type
I outcomes, 47 percent were discharged to skilled-
nursing facilities or rehabilitation centers, as com-
pared with 30 percent of patients with type II out-
comes and 8 percent of patients without adverse
cerebral outcomes.
 
DISCUSSION
 
This study was a large multicenter, prospective
investigation of adverse cerebral outcomes after elec-
tive CABG surgery. Serious adverse cerebral out-
comes occurred in 6.1 percent of patients, evenly di-
vided between type I outcomes (fatal cerebral injury
and nonfatal strokes) and type II (new deterioration
in intellectual function or new onset of seizures).
Adverse cerebral outcomes were associated with sig-
nificantly increased mortality and use of medical re-
sources. There was a 5-to-10-fold increase in mortal-
ity associated with type I and type II outcomes;
furthermore, the 21 percent mortality rate found
with perioperative stroke is similar to the rate report-
ed from a single center more than a decade ago and
suggests that stroke-related mortality has not de-
creased over the past decade.
 
6
 
 The duration of inten-
sive care and of the total hospital stay was prolonged
by both type I and type II outcomes — a finding not
previously reported with type II outcomes. High-risk
characteristics were identified; they included, among
others, advanced age, proximal aortic atherosclerosis,
neurologic disease, pulmonary disease, and a history
of or existing hypertension. These results emphasize
the medical importance of adverse cerebral outcomes
after CABG surgery; they have economic implica-
tions as well.
 
1,3,13
 
 
 
*History of carotid disease includes carotid bruit, stenosis, and carotid endarterectomy. Excessive alcohol consumption
indicates hospitalization because of alcohol consumption or alcohol withdrawal. CABG denotes coronary-artery bypass
graft.
†These conditions were assessed in the intensive care unit immediately after surgery.
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CHARACTERISTIC
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PATIENTS
WITHOUT
CHARACTERISTIC
 
percent
 
Age 
 

 
70 yr
Medical history*
31.9 6.1 1.9 5.8 1.8
Neurologic disease 8.3 10.1 2.5 4.7 2.9
Carotid disease 14.7 7.8 2.5 4.5 2.8
Valve disease 19.9 6.14 1.3 4.6 2.1
Dysrhythmia 11.3 3.6 3.2 5.7 2.8
Unstable angina 47.7 4.4 2.2 3.7 2.4
CABG 12.9 6.2 2.8 5.5 2.7
Peripheral vascular disease 13.8 6.5 2.7 5.9 2.7
Congestive heart failure 26.4 4.9 2.6 4.9 2.4
Myocardial infarction 55.4 3.9 2.2 3.2 3.0
Diabetes mellitus 25.1 5.5 2.4 3.4 3.0
Pulmonary disease 17.5 6.1 2.7 6.3 2.4
Excessive alcohol consumption 9.8 5.6 3.0 5.6 2.8
Hypertension 57.2 4.5 1.6 3.3 2.4
Preoperative factors
Systolic blood pressure
 

 
180 mm Hg 
2.9 11.0 3.0 12.5 2.8
Antihypertensive therapy 20.7 4.6 2.9 5.7 2.4
Intraoperative factors
Proximal aortic atherosclerosis 12.4 11.2 2.1 5.2 2.8
Intraoperative hypotension 10.6 6.2 2.9 6.2 2.7
Use of intraaortic balloon pump 7.6 9.0 2.8 4.1 3.0
Ventricular or atrial venting 76.3 3.6 1.9 3.4 2.1
Postoperative factors†
Congestive heart failure 2.6 10.2 3.1 10.2 2.9
Dysrhythmia 18.0 3.6 3.1 5.7 2.5
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We examined conservative measures of resource
use — namely, the duration of intensive care, the to-
tal duration of the hospital stay after surgery, and
the rate of discharge to intermediate- or long-term
care facilities. All three measures were markedly pro-
longed for patients with either type I or type II ad-
verse neurologic outcomes. As compared with pa-
tients without adverse cerebral outcomes, patients
with stroke stayed an additional eight days in the
intensive care unit and an additional seven days on
the ward, suggesting that regardless of institutional
practice, substantial resources are consumed by such
patients. This confirms previous findings from sin-
gle-center studies.
 
2,4,10,14
 
 Again as compared with pa-
tients without adverse cerebral outcomes, patients
with type II outcomes stayed an additional four days
in the intensive care unit and seven days on the
ward. On the basis of conservative estimates of board-
ing charges of $890 per day in an intensive care unit
and $370 per day on a ward,
 
1,14
 
 type I neurologic
events are responsible for an additional $10,266 per
patient in in-hospital boarding costs, and type II
events for an additional $6,150 per patient.
 
1-3,10,14
 
 If
we apply these estimates to the 800,000 patients per
year who undergo CABG surgery throughout the
world, the additional in-hospital cost is approximate-
ly $400 million annually.
 
1
 
 True in-hospital costs, in-
cluding charges for personnel and in-hospital servic-
es, if added to the expense of an array of long-term
out-of-hospital medical and rehabilitative services,
probably result in an additional expenditure ranging
from 5 to 10 times the narrowly defined in-hospital
costs, or some $2 billion to $4 billion annually.
 
1
 
 As
an example of the increased cost, consider that 90
percent of patients without adverse cerebral out-
comes were discharged to their homes, as compared
with only 32 percent of patients with type I outcomes
and 60 percent with type II outcomes. Whether the
need for prolonged hospitalization and the changes
in discharge patterns are caused directly by the neu-
rologic complications or by other associated illness
is uncertain, yet it is likely that adverse cerebral out-
comes affect the use of health care resources pro-
foundly.
Predictors Unique to Type I Outcomes
Moderate-to-severe proximal aortic atherosclero-
sis, as identified by intraoperative palpation of the
*Odds ratios are for the risk of a type I or II outcome in patients with the risk factor in question
as compared with those without the risk factor. Odds ratios have been adjusted for all the factors
listed for each model. Excessive alcohol consumption indicates hospitalization because of alcohol
consumption or alcohol withdrawal. Perioperative hypotension indicates a systolic blood pressure
80 mm Hg (during surgery but before cardiopulmonary bypass, or after bypass) or 40 mm Hg
(during bypass) for more than 10 minutes. CABG denotes coronary-artery bypass graft.
†In addition to factors from Table 1, the following characteristics, studied in univariable analysis,
did not remain in the model: sex, aortic cross-clamping, duration of cardiopulmonary bypass and
surgery, and institution.
TABLE 2. ADJUSTED ODDS RATIOS FOR TYPE I AND TYPE II CEREBRAL OUTCOMES
ASSOCIATED WITH SELECTED RISK FACTORS.*
FACTOR
MODEL FOR TYPE I
CEREBRAL OUTCOME
MODEL FOR TYPE II
CEREBRAL OUTCOME
odds ratio (95% confidence interval)
Significant factors (P0.05)
Proximal aortic atherosclerosis 4.52 (2.52–8.09)
History of neurologic disease 3.19 (1.65–6.15)
Use of intraaortic balloon pump 2.60 (1.21–5.58)
Diabetes mellitus 2.59 (1.46–4.60)
History of hypertension 2.31 (1.20–4.47)
History of pulmonary disease 2.09 (1.14–3.85) 2.37 (1.34–4.18)
History of unstable angina 1.83 (1.03–3.27)
Age (per additional decade) 1.75 (1.27–2.43) 2.20 (1.60–3.02)
Systolic blood pressure 180 mm Hg at admission 3.47 (1.41–8.55)
History of excessive alcohol consumption 2.64 (1.27–5.47)
History of CABG 2.18 (1.14–4.17)
Dysrhythmia on day of surgery 1.97 (1.12–3.46)
Antihypertensive therapy 1.78 (1.02–3.10)
Other factors (P not significant)†
Perioperative hypotension 1.92 (0.93–3.97) 1.88 (0.97–3.65)
Ventricular venting 1.83 (0.86–3.90)
Congestive heart failure on day of surgery 2.46 (0.85–7.09)
History of peripheral vascular disease 1.64 (0.89–3.04)
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aorta, was associated with an incidence of type I ad-
verse cerebral outcomes at least four times that
among patients without the condition. This finding
supports the theory that most strokes are caused by
large atherosclerotic emboli liberated by surgical
manipulation of the aorta.3,15-22 In our study, proxi-
mal aortic atherosclerosis, detected by palpation, was
found in approximately 12 percent of all patients
and in 20 percent of patients 70 years of age.
Moderate or severe atherosclerotic disease has been
detected with ultrasonographic scanning in 14 to 20
percent of elderly patients.3,23-27 Although palpation
of the aorta is not as sensitive a measure as other
techniques, such as echocardiography, the method is
simple and can be used routinely to identify patients
at risk and therefore to indicate alterations in surgi-
cal technique. Such alterations might include the ad-
justment of the site for aortic clamping and cannu-
lation, to avoid atherosclerotic regions; the use of
arterial conduits (e.g., internal thoracic or epigastric
arteries) to avoid aortic anastomoses; the use of hy-
pothermic fibrillatory arrest without clamping the
aorta; or the use of hypothermic circulatory arrest,
with replacement of the diseased aorta.1,3,4,24,27-30 
A history of neurologic abnormality — for exam-
ple, stroke or TIA — was also a significant risk factor
for type I outcomes, a finding consistent with those
of other studies.7,31 A history of neurologic disease
suggests existing pathologic cerebrovascular condi-
tions, such as impaired cerebral blood flow and au-
toregulation or inadequate collateral vessels, which
may predispose patients to a type I cerebral compli-
cation after CABG surgery. Patients with diabetes
mellitus also had an increased risk of a type I out-
come, perhaps reflecting these patients’ impaired
autoregulation during bypass3,4,15,32 or more gener-
alized atherosclerosis, involving the aorta or the
carotid or cerebral arteries. Unstable angina has been
associated with a prothrombotic state and systemic
immunologic-cascade activation that may contribute
to the development of neurologic injury.33 The use
of a left ventricular venting procedure was weakly as-
sociated with the occurrence of a type I adverse neu-
rologic outcome, but the relatively small number of
patients without vents limited statistical assessment.
The placement of a vent may introduce air into the
left side of the heart that subsequently embolizes
and travels to the brain3,4,19,34 — a danger that high-
lights the importance of fastidious surgical tech-
nique if a vent is used. A final factor, the use of an
intraaortic balloon pump, may be associated with
the dislodgment of aortic emboli or may be a mark-
er of hypoperfusion.
Predictors Unique to Type II Outcomes
Proximal aortic atherosclerosis was not an in-
dependent predictor of type II cerebral outcomes,
suggesting that large atherosclerotic emboli do not
have a primary role in the pathophysiology of en-
cephalopathy or seizures after bypass surgery. This is
consistent with previous studies demonstrating an
association between small emboli, or inadequate
cerebral flow, and type II outcomes.1,3,4,35,36 Risk
factors unique to type II outcomes were a history of
excessive alcohol consumption; postoperative dys-
rhythmia (mainly, atrial fibrillation), which may in-
duce cerebral emboli or hypoperfusion14; and a his-
tory of CABG or peripheral vascular disease, which
may reflect more advanced atherosclerosis.
Predictors of Both Type I and Type II Outcomes
Advanced age, particularly an age of 70 or more,
was a leading factor associated with both type I and
type II adverse cerebral outcomes. Aging is associat-
ed with atherosclerosis and an increased risk of em-
bolic phenomena, as well as with alterations in cer-
ebral vasculature3,4,6,7,15,17,37-40 and the autoregulation
of blood flow,8,41-43 all of which may increase the in-
Figure 1. Incidence of Type I and Type II Cerebral Outcomes Ac-
cording to Age.
0
10
80
8
6
4
2
40 – 49 50 – 59 60 – 69 70 –79
Age (yr)
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d
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 (
%
)
40
Type I
Type II
*P0.001 for all comparisons among the groups. ICU denotes intensive
care unit.
†Patients not discharged to their homes either died or were discharged
to intermediate- or long-term care facilities.
TABLE 3. MORTALITY AND POSTOPERATIVE RESOURCE USE,
ACCORDING TO CEREBRAL OUTCOME.*
VARIABLE
TYPE I
OUTCOME
(N66)
TYPE II
OUTCOME
(N63)
NO ADVERSE
CEREBRAL EVENT
(N1979)
Death during hospitalization — 
no. (%)
14 (21) 6 (10) 38 (2)
Duration of postoperative hos-
pital stay — days
Mean SD
Median
25.322.2
17.6
20.525.2
10.9
9.512.4
7.7
Duration of ICU stay — days
Mean SD
Median
11.115.4
5.8
6.67.9
3.2
2.63.5
1.9
Discharged to home — no. (%)† 21 (32) 38 (60) 1773 (90)
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cidence of perioperative stroke, cognitive dysfunc-
tion, and delirium.3,4,6,7,15,18,28,38-40,44,45 Pulmonary
disease (emphysema, chronic bronchitis, restrictive
lung disease, or asthma), a previously unreported
risk factor for either type I or type II outcomes,
was in our study a significant predictor of both; pa-
tients with pulmonary disease probably retained
carbon dioxide (thus affecting cerebral vasoreactiv-
ity) or required prolonged mechanical ventilation
(thus affecting the degree of cerebral perfusion and
oxygenation).1,3,16,28,46 Both a history of hyperten-
sion and existing hypertension were associated with
adverse cerebral outcomes — a reflection of im-
paired cerebrovascular autoregulation and more
generalized atherosclerotic disease in hypertensive
patients.
Strengths and Limitations of the Study
The reported incidence of perioperative stroke in
studies from only one center varies by a factor of
more than 10, from 0.4 to 5.4 percent,1-4,8,16,47 with
similar variability in the rates of encephalopathy, de-
lirium, and confusion. Most likely, this variability is
due to differences in study design (for instance,
whether the studies were retrospective or prospec-
tive), methods, sample size, and the effects of site-
specific factors.1-3,9,48,49 Our study addressed these
limitations by enrolling patients at multiple diverse
institutions, thereby minimizing distortion due to
the effects of surgical, anesthetic, perfusion-related,
and medical practices specific to a single center; ran-
domizing enrollment and limiting it to a period of
24 months in order to decrease the impact of tem-
poral changes in practice; collecting data prospec-
tively; and excluding procedures, such as valve re-
placement or aneurysmectomy, that might increase
a patient’s risk of adverse neurologic events.4,20,31 
Our study, however, has several limitations of its
own. First, the neurologic findings were assessed by
investigators at each site, not by a single neurologist
performing all preoperative and postoperative exam-
inations; there may be significant variations in clini-
cal practice, and thus diagnosis, among the 24 cen-
ters (although no site-related effect was identified).
Second, neuropsychological deficits were not for-
mally assessed because of several constraints, includ-
ing a lack of technical experience in neuropsycho-
logical testing and the time required for such
testing. Our assessment of deterioration in intellec-
tual function is thus open to criticism. Third, our
categorization of outcomes as type I or type II pre-
sumed differences in the characteristic mechanisms
of injury in the two types — focal and diffuse,
respectively35,36 (although this presumption is consis-
tent with our finding that few of the predictors in
the multivariable analysis of type I and type II out-
comes were similar). Fourth, we detected aortic ath-
erosclerosis by surgical palpation. Recent studies
have shown that ultrasonography is superior to pal-
pation in detecting aortic atheromas, but our study
was designed and our data collected before the pub-
lication of those reports. Finally, several recent studies
suggest an association between the presence of carot-
id-artery stenosis, as documented by carotid duplex
scanning, and stroke after cardiac surgery.1,3,4,24,31 We
found a strong univariable correlation between the
presence of carotid disease (including carotid bruit,
stenosis, or endarterectomy) and type I cerebral out-
comes (P0.001), but carotid duplex scanning was
not performed as part of the study. Perhaps because
of the relatively poor specificity and selectivity of ca-
rotid bruit as a sign of hemodynamically important
lesions, we were unable to document an association
between carotid disease and adverse cerebral out-
come in the multivariable analysis.
On the basis of data from 24 U.S. medical centers,
we conclude that adverse perioperative cerebral out-
comes are both relatively common (they occur in 6.1
percent of patients) and serious. As compared with
patients with no adverse outcomes, the patients with
such outcomes had 5 to 10 times the mortality, 2 to
4 times the time spent in intensive care and in the
hospital, and 3 to 6 times the need for prolonged
care. We were able to identify patients at high risk
both for focal and for diffuse injury, thereby allow-
ing improved stratification of risk. Further investiga-
tion is necessary, however, to develop diagnostic and
therapeutic strategies1,3,49 to reduce mortality and
morbidity and to conserve resources.
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